UTA awards 2016 Interdisciplinary Research Program grants to address high-priority issues

August 30, 2016

UTA has awarded four seed grants to interdisciplinary research projects that address growing problems such as loneliness among the elderly, the need for sustainable green education spaces, the health crisis among urban American Indians or the mechanisms behind heart failure among the elderly.

"All these awards represent important research innovations and could create a real impact in society," said Duane Dimos, UTA vice president for research. "By taking advantage of the multiple perspectives offered by interdisciplinary research, the winning teams have proposed new ways of attacking real world problems, demonstrating yet again the commitment of our faculty to the highest level of scholarship."

The winning proposals include: Jon Weidanz, associate vice president for research and manager of the program, underscored the role that these projects play in strengthening the University's focus on the themes of health and the human condition, sustainable urban communities, global environmental impact and data-driven discovery, all tenets of the Strategic Plan 2020: Bold Solutions | Global Impact.

"UTA is building multidisciplinary expertise around these four themes as they cover most of the pressing needs of our society," Weidanz said. "Multidisciplinary research also has a higher impact and makes us more competitive for externally funded grant opportunities."

The Interdisciplinary Research Awards provide $20,000 to help the research groups advance their efforts to the level where the team can compete for externally funded, competitive grants from the corporate world and agencies such as the National Science Foundation, the National Institutes of Health, NASA, the Department of Defense, and others.

Some of last year's inaugural Interdisciplinary Research Program winners have already disclosed inventions to the University's Office of Technology Management, which is evaluating them with respect to patentability and marketability. Other groups are in the process of publishing studies in reputable journals or developing papers for conferences, or have applied for additional funding opportunities.

"These grants have already helped raise the profile of the University as a leader in research and a fount of innovation and entrepreneurship," Weidanz concluded. "We are proud of our faculty's commitment to excellence in research."
-end-
About The University of Texas at Arlington

The University of Texas at Arlington is a Carnegie Research-1 "highest research activity" institution of about 55,000 students in campus-based and online degree programs and is the second-largest institution in The University of Texas System. U.S. News & World Report ranks UTA fifth in the nation for undergraduate diversity. The University is a Hispanic-Serving Institution and is ranked as the top four-year college in Texas for veterans on Military Times' 2016 Best for Vets list. Visit http://www.uta.edu to learn more, and find UTA rankings and recognition at http://www.uta.edu/uta/about/rankings.php.

For more on the Strategic Plan, see Strategic Plan 2020: Bold Solutions | Global Impact.

University of Texas at Arlington

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.